Cargando…

A novel DNA repair‐related nomogram predicts survival in low‐grade gliomas

AIMS: We aimed to create a tumor recurrent‐based prediction model to predict recurrence and survival in patients with low‐grade glioma. METHODS: This study enrolled 291 patients (188 in the training group and 103 in the validation group) with clinicopathological information and transcriptome sequenc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Guanzhang, Wu, Fan, Zeng, Fan, Zhai, You, Feng, Yuemei, Chang, Yuanhao, Wang, Di, Jiang, Tao, Zhang, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7816205/ https://www.ncbi.nlm.nih.gov/pubmed/33063446 http://dx.doi.org/10.1111/cns.13464

Ejemplares similares

Single-Cell RNA-Sequencing Shift in the Interaction Pattern Between Glioma Stem Cells and Immune Cells During Tumorigenesis
por: Zhai, You, et al.
Publicado: (2020)

Redox Regulator GLRX Is Associated With Tumor Immunity in Glioma
por: Chang, Yuanhao, et al.
Publicado: (2020)

TREM2 is associated with tumor immunity and implies poor prognosis in glioma
por: Yu, Mingchen, et al.
Publicado: (2023)

DNA Methylation-Driven Genes for Developing Survival Nomogram for Low-Grade Glioma
por: Guo, Yingyun, et al.
Publicado: (2022)

Uronic acid metabolic process–related gene expression–based signature predicts overall survival of glioma
por: Feng, Yuemei, et al.
Publicado: (2021)

A novel methylation signature predicts radiotherapy sensitivity in glioma
por: Feng, Yuemei, et al.
Publicado: (2020)

RPP30, a transcriptional regulator, is a potential pathogenic factor in glioblastoma
por: Li, Guanzhang, et al.
Publicado: (2020)

A novel gene signature based on five immune checkpoint genes predicts the survival of glioma
por: Zhang, Wei, et al.
Publicado: (2021)

Galectin-9/TIM-3 as a Key Regulator of Immune Response in Gliomas With Chromosome 1p/19q Codeletion
por: Li, Guanzhang, et al.
Publicado: (2021)

Association of high‐dose radiotherapy with improved survival in patients with newly diagnosed low‐grade gliomas
por: Liu, Yanwei, et al.
Publicado: (2021)

CKAP2 expression is associated with glioma tumor growth and acts as a prognostic factor in high-grade glioma
por: Wang, Kuanyu, et al.
Publicado: (2018)

Molecular Characterization and Clinical Relevance of ANXA1 in Gliomas via 1,018 Chinese Cohort Patients
por: Qian, Zenghui, et al.
Publicado: (2021)

High-dose radiation associated with improved survival in IDH-wildtype low-grade glioma
por: Liu, Shuai, et al.
Publicado: (2021)

Clinical characterization and immunosuppressive regulation of CD161 (KLRB1) in glioma through 916 samples
por: Di, Wang, et al.
Publicado: (2021)

An MRI radiomics approach to predict survival and tumour-infiltrating macrophages in gliomas
por: Li, Guanzhang, et al.
Publicado: (2022)

Postoperative standard chemoradiotherapy benefits primary glioblastoma patients of all ages
por: Li, Guanzhang, et al.
Publicado: (2019)

NK Cell-Based Immunotherapy and Therapeutic Perspective in Gliomas
por: Pan, Changqing, et al.
Publicado: (2021)

A potentially effective drug for patients with recurrent glioma: sermorelin
por: Chang, Yuanhao, et al.
Publicado: (2021)

EFEMP2 indicates assembly of M0 macrophage and more malignant phenotypes of glioma
por: Huang, Lijie, et al.
Publicado: (2020)

Comparative profiling of immune genes improves the prognoses of lower grade gliomas
por: Wang, Zhiliang, et al.
Publicado: (2022)

Prognostic Model and Nomogram Construction and Validation With an Autophagy-Related Gene Signature in Low-Grade Gliomas
por: Li, Xinrui, et al.
Publicado: (2022)

Comprehensive Analysis of the Clinical and Biological Significances of Endoplasmic Reticulum Stress in Diffuse Gliomas
por: Huang, Ruoyu, et al.
Publicado: (2021)

A new glioma grading model based on histopathology and Bone Morphogenetic Protein 2 mRNA expression
por: Zhou, Kaijia, et al.
Publicado: (2020)

Corrigendum: Comprehensive analysis of the clinical and biological significances of endoplasmic reticulum stress in diffuse gliomas
por: Huang, Ruoyu, et al.
Publicado: (2022)

Development of Autophagy Signature-Based Prognostic Nomogram for Refined Glioma Survival Prognostication
por: Fan, Yuxiang, et al.
Publicado: (2020)

Multimodal MRI-Based Radiomic Nomogram for the Early Differentiation of Recurrence and Pseudoprogression of High-Grade Glioma
por: Jing, Hui, et al.
Publicado: (2022)

Identification of a Nomogram with an Autophagy-Related Risk Signature for Survival Prediction in Patients with Glioma
por: Fu, Xiaofeng, et al.
Publicado: (2022)

A survival analysis of surgically treated incidental low-grade glioma patients
por: Zeng, Lingcheng, et al.
Publicado: (2021)

Chinese Glioma Genome Atlas (CGGA): A Comprehensive Resource with Functional Genomic Data from Chinese Glioma Patients
por: Zhao, Zheng, et al.
Publicado: (2021)

Receptor tyrosine kinase expression in high-grade gliomas before and after chemoradiotherapy
por: Wang, Kuanyu, et al.
Publicado: (2019)

Survival analysis of immune-related lncRNA in low-grade glioma
por: Li, Xiaozhi, et al.
Publicado: (2019)

Added Value of Cognition in the Prediction of Survival in Low and High Grade Glioma
por: van Kessel, Emma, et al.
Publicado: (2021)

Behavior-Oriented Nomogram for the Stratification of Lower-Grade Gliomas to Improve Individualized Treatment
por: Wei, Ruo-Lun, et al.
Publicado: (2020)

Chemotherapy and diffuse low-grade gliomas: a survey within the European Low-Grade Glioma Network
por: Darlix, Amélie, et al.
Publicado: (2019)

Identification of an ATP metabolism‐related signature associated with prognosis and immune microenvironment in gliomas
por: Huang, Ruoyu, et al.
Publicado: (2020)

Management of Low-Grade Glioma
por: Pouratian, Nader, et al.
Publicado: (2010)

Pediatric Low-Grade Gliomas
por: Collins, Kelly L., et al.
Publicado: (2020)

Pseudoprogression in low-grade glioma
por: Slater, Jason M., et al.
Publicado: (2019)

Radiogenomics of lower-grade gliomas: a radiomic signature as a biological surrogate for survival prediction
por: Qian, Zenghui, et al.
Publicado: (2018)

Classification of diffuse lower‐grade glioma based on immunological profiling
por: Wu, Fan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7de4goh9547g3vu1f8imo9jqr9